4.6 Article

The Nuclear Receptor PXR in Chronic Liver Disease

Related references

Note: Only part of the references are listed.
Review Immunology

Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities

Yankai Wen et al.

Summary: Macrophages, key cellular components of the liver, play essential roles in maintaining liver homeostasis, injury and repair processes in liver diseases. Kupffer cells and monocyte-derived macrophages contribute significantly to tissue inflammation and injury, but exhibit different functional responses in distinct liver diseases.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Toxicology

The influence of the long-term chemical activation of the nuclear receptor pregnane X receptor (PXR) on liver carcinogenesis in mice

Ryota Shizu et al.

Summary: The activation of PXR does not promote hepatocarcinogenesis in mice, but rather attenuates CAR-mediated liver cancer development by suppressing the EMT of liver cancer cells.

ARCHIVES OF TOXICOLOGY (2021)

Article Biochemistry & Molecular Biology

Splice variants of metabolic nuclear receptors: Relevance for metabolic disease and therapeutic targeting

Anna Mukha et al.

Summary: This review discusses the splice variants of metabolic nuclear receptors and their regulation of different metabolic pathways by nutritional signals. These NR splice variants add an intriguing new layer of complexity to metabolic signaling.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Article Environmental Sciences

An adverse outcome pathway based in vitro characterization of novel flame retardants-induced hepatic steatosis

Chander K. Negi et al.

Summary: A wide range of novel replacement flame retardants (nFRs) are increasingly detected in the environment and human matrices, with evidence suggesting potential association of nFRs exposure with disruption of the endocrine system and metabolic disorders such as NAFLD. In vitro assays showed that several tested OPFRs induced lipid accumulation in human liver cell cultures, pointing to potential molecular targets like pregnane X receptor (PXR) and peroxisome proliferator-activated receptor gamma (PPAR gamma) for the tested nFRs. The study highlights the risk factors of certain nFRs for NAFLD and showcases the efficacy of an AOP-based strategy in elucidating molecular mechanisms of toxicity.

ENVIRONMENTAL POLLUTION (2021)

Review Cell Biology

Targeting the alternative bile acid synthetic pathway for metabolic diseases

Wei Jia et al.

Summary: The gut microbiota plays a significant role in glucose and lipid metabolism by regulating bile acid metabolism and affecting multiple signaling pathways. Bile acids are synthesized in the liver through two distinct pathways, influencing cholesterol and lipid catabolism and activating various signaling pathways. Modulating bile acid synthesis and composition could be a novel approach for developing therapies for metabolic diseases.

PROTEIN & CELL (2021)

Review Gastroenterology & Hepatology

Treatment of primary sclerosing cholangitis

Annarosa Floreani et al.

Summary: PSC is a chronic cholestatic liver disease with no effective treatment currently available. There is controversy over the use of UDCA in PSC treatment. Novel pharmacological strategies targeting bile composition, immunomodulation, gut microbiome, and fibrosis are emerging, suggesting potential for personalized combination therapies for successful PSC treatment.

DIGESTIVE AND LIVER DISEASE (2021)

Review Chemistry, Medicinal

Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches

Adrian Hall et al.

Summary: This perspective emphasizes the importance of reducing PXR activity in drug discovery, and summarizes the use of structural biology to understand molecular interactions and structural modifications for this purpose. The computational approaches for designing new drugs devoid of PXR activation potential are highlighted, and the SAR of empirical design strategies to reduce PXR activity is reviewed.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Nutrition & Dietetics

The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver

Daniela Gabbia et al.

Summary: This study evaluated the anti-fibrotic and anti-inflammatory effects of oleocanthal extracted from extra virgin olive oil. Results showed that OC can significantly downregulate fibrotic and inflammatory gene expression, offering a promising therapeutic approach for liver fibrosis.

FRONTIERS IN NUTRITION (2021)

Article Microbiology

The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice

Sharon Ann Barretto et al.

Summary: This study identified PXR as a hepatic effector of microbiota-derived signals that regulate sexually dimorphic lipid and xenobiotic metabolisms in the liver. These findings reveal a potential new mechanism for unexpected drug-drug interactions.

MICROBIOME (2021)

Article Biochemistry & Molecular Biology

The xenobiotic receptors PXR and CAR in liver physiology, an update

Xinran Cai et al.

Summary: PXR and CAR, two nuclear receptors highly expressed in the liver, have major potentials to affect liver pathophysiology by regulating the homeostasis of endobiotics.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Review Nutrition & Dietetics

The Role of Vitamin K in Cholestatic Liver Disease

Halima Sultana et al.

Summary: Vitamin K plays a critical role in liver diseases, particularly in conditions related to cholestasis. By modulating PXR, vitamin K may have a positive impact on cholestasis and liver fibrosis.

NUTRIENTS (2021)

Review Biochemistry & Molecular Biology

The Role of Oxidative Stress in NAFLD-NASH-HCC Transition-Focus on NADPH Oxidases

Daniela Gabbia et al.

Summary: Oxidative stress plays a significant role in the progression of non-alcoholic fatty liver disease (NAFLD) to more severe complications including non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). NADPH oxidases (NOXs) are enzymes that produce reactive oxygen species (ROS) and their abundance in liver cells is closely related to inflammation and immune responses. The differential effects of NOX isoforms, such as NOX1, NOX2, and NOX4, on liver disease progression and HCC prognosis require further investigation.

BIOMEDICINES (2021)

Article Gastroenterology & Hepatology

Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis

Nora Cazzagon et al.

Summary: The study found that cellular senescence marker expression exists in cholangiocytes of PSC patients, which is related to the severity of the disease and patient outcomes. CS may serve as a new prognostic tool and potential therapeutic target in PSC.

JHEP REPORTS (2021)

Article Obstetrics & Gynecology

Developmental regulation of the gut-liver (FGF19-CYP7A1) axis in neonates

Naureen Memon et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2020)

Review Pharmacology & Pharmacy

PXR: a center of transcriptional regulation in cancer

Yaqi Xing et al.

ACTA PHARMACEUTICA SINICA B (2020)

Review Pharmacology & Pharmacy

Drug Therapies for Chronic Cholestatic Liver Diseases

Martin Wagner et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)

Review Chemistry, Medicinal

Strategies for developing pregnane X receptor antagonists: Implications from metabolism to cancer

Sergio C. Chai et al.

MEDICINAL RESEARCH REVIEWS (2020)

Review Gastroenterology & Hepatology

Primary biliary cholangitis: pathogenesis and therapeutic opportunities

Aliya F. Gulamhusein et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Cell Biology

Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis

Vincenzo Ronca et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2020)

Article Pharmacology & Pharmacy

Phosphorylation Modulates the Coregulatory Protein Exchange of the Nuclear Receptor Pregnane X Receptor

Wenqi Cui et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)

Review Cell Biology

Regulation of CAR and PXR Expression in Health and Disease

Martine Daujat-Chavanieu et al.

CELLS (2020)

Review Biochemistry & Molecular Biology

Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues

Maurizio Parola et al.

MOLECULAR ASPECTS OF MEDICINE (2019)

Review Oncology

Molecular Pathogenesis of Cholangiocarcinoma

Peter L. Labib et al.

BMC CANCER (2019)

Review Gastroenterology & Hepatology

Anatomical, histomorphological and molecular classification of cholangiocarcinoma

Timothy Kendall et al.

LIVER INTERNATIONAL (2019)

Review Gastroenterology & Hepatology

Cholangiocarcinoma: Epidemiology and risk factors

Shahid A. Khan et al.

LIVER INTERNATIONAL (2019)

Review Physiology

FGF21 as Modulator of Metabolism in Health and Disease

Caterina Tezze et al.

FRONTIERS IN PHYSIOLOGY (2019)

Review Pharmacology & Pharmacy

Role of Nuclear Receptors PXR and CAR in Xenobiotic-Induced Hepatocyte Proliferation and Chemical Carcinogenesis

Kouichi Yoshinari

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)

Review Medicine, General & Internal

Extrahepatic autoimmunity in autoimmune liver disease

Annarosa Floreani et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)

Review Medical Laboratory Technology

Bile acids and the metabolic syndrome

Emma Rose McGlone et al.

ANNALS OF CLINICAL BIOCHEMISTRY (2019)

Review Gastroenterology & Hepatology

Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

Wei Jia et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Review Pharmacology & Pharmacy

The Roles of Xenobiotic Receptors: Beyond Chemical Disposition

Bryan Mackowiak et al.

DRUG METABOLISM AND DISPOSITION (2018)

Review Gastroenterology & Hepatology

Novel and emerging therapies for cholestatic liver diseases

Jordan Goldstein et al.

LIVER INTERNATIONAL (2018)

Review Gastroenterology & Hepatology

Liver fibrosis

M. Merve Aydin et al.

TURKISH JOURNAL OF GASTROENTEROLOGY (2018)

Review Biochemistry & Molecular Biology

The nuclear receptor superfamily: A structural perspective

Emily R. Weikum et al.

PROTEIN SCIENCE (2018)

Article Multidisciplinary Sciences

Exploring the PXR ligand binding mechanism with advanced Molecular Dynamics methods

Stefano Motta et al.

SCIENTIFIC REPORTS (2018)

Article Gastroenterology & Hepatology

Hepatic Nuclear Receptor Expression Associates with Features of Histology in Pediatric Nonalcoholic Fatty Liver Disease

Erin E. Elbel et al.

HEPATOLOGY COMMUNICATIONS (2018)

Review Gastroenterology & Hepatology

Primary sclerosing cholangitis - a comprehensive review

Tom H. Karlsen et al.

JOURNAL OF HEPATOLOGY (2017)

Article Pharmacology & Pharmacy

PXR: More Than Just a Master Xenobiotic Receptor

Peter O. Oladimeji et al.

MOLECULAR PHARMACOLOGY (2017)

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis

Nicha Wongjarupong et al.

BMC GASTROENTEROLOGY (2017)

Review Gastroenterology & Hepatology

Role of pregnane X-receptor in regulating bacterial translocation in chronic liver diseases

Sundhar Mohandas et al.

WORLD JOURNAL OF HEPATOLOGY (2017)

Article Biochemistry & Molecular Biology

PXR stimulates growth factor-mediated hepatocyte proliferation by cross-talk with the FOXO transcription factor

Ryota Shizu et al.

BIOCHEMICAL JOURNAL (2016)

Article Biochemistry & Molecular Biology

Mechanisms of xenobiotic receptor activation: Direct vs. indirect

Bryan Mackowiak et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)

Article Biochemistry & Molecular Biology

Nuclear receptors and nonalcoholic fatty liver diseases

Matthew C. Cave et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)

Article Gastroenterology & Hepatology

Soluble Adenylyl Cyclase Regulates Bile Salt-Induced Apoptosis in Human Cholangiocytes

Jung-Chin Chang et al.

HEPATOLOGY (2016)

Article Public, Environmental & Occupational Health

Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP rats

Hisao Naito et al.

ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2016)

Review Pharmacology & Pharmacy

A brief history of the discovery of PXR and CAR as xenobiotic receptors

Jiong Yan et al.

ACTA PHARMACEUTICA SINICA B (2016)

Review Physiology

Bile Acids, Nuclear Receptors and Cytochrome P450

J. Jurica et al.

PHYSIOLOGICAL RESEARCH (2016)

Article Pharmacology & Pharmacy

Pregnane X Receptor-Humanized Mice Recapitulate Gender Differences in Ethanol Metabolism but Not Hepatotoxicity

Krisstonia Spruiell et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)

Article Gastroenterology & Hepatology

Characterization of a novel PXR isoform with potential dominant-negative properties

Cyril Breuker et al.

JOURNAL OF HEPATOLOGY (2014)

Review Biochemistry & Molecular Biology

Bile acids are nutrient signaling hormones

Huiping Zhou et al.

STEROIDS (2014)

Article Pharmacology & Pharmacy

Differential Effect of Liver Cirrhosis on the Pregnane X Receptor-Mediated Induction of CYP3A1 and 3A2 in the Rat

Sara De Martin et al.

DRUG METABOLISM AND DISPOSITION (2014)

Article Gastroenterology & Hepatology

Changes of Organic Anion Transporter MRP4 and Related Nuclear Receptors in Human Obstructive Cholestasis

Jin Chai et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2011)

Article Oncology

Impact of bile acids on the growth of human cholangiocarcinoma via FXR

Jiaqi Dai et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)

Review Gastroenterology & Hepatology

NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma

Tom Luedde et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)

Article Biochemistry & Molecular Biology

The alternatively spliced murine pregnane X receptor isoform, mPXRΔ171-211 exhibits a repressive action

Marko Matic et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)

Article Biochemistry & Molecular Biology

The PXR is a drug target for chronic inflammatory liver disease

Karen Wallace et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)

Article Biotechnology & Applied Microbiology

The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease

Silvia Sookoian et al.

PHARMACOGENETICS AND GENOMICS (2010)

Article Chemistry, Medicinal

Identifying and Characterizing Binding Sites and Assessing Druggability

Thomas A. Halgren

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)

Article Gastroenterology & Hepatology

Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease

Mario Congiu et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)

Article Gastroenterology & Hepatology

Genetic factors of susceptibility and of severity in primary biliary cirrhosis

Raoul Poupon et al.

JOURNAL OF HEPATOLOGY (2008)

Article Pharmacology & Pharmacy

Enzyme Inhibition and Induction in Liver Disease

Pietro Palatini et al.

CURRENT CLINICAL PHARMACOLOGY (2008)

Article Biochemistry & Molecular Biology

Microarray analysis of gene expression of mouse hepatocytes of different ploidy

Pin Lu et al.

MAMMALIAN GENOME (2007)

Article Gastroenterology & Hepatology

Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro

Emma L. Haughton et al.

GASTROENTEROLOGY (2006)

Article Multidisciplinary Sciences

Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor

W Xie et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Multidisciplinary Sciences

The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

JL Staudinger et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)